T he peptidoglycan layer is present in virtually all bacteria and is essential for its survival and growth. This layer is classically described as a structural component that is assembled outside the membrane, that is largely cross-linked by 4¡3 transpeptide linkages, and that gives shape and turgidity to the cell but otherwise is not dynamic (1). Based on this paradigm of peptidoglycan biology, 3¡3 transpeptide linkages observed in Mycobacterium spp. and Escherichia coli were considered unusual and were speculated to be modifications or derivatives of 4¡3 linkages (2-5). Recent studies have demonstrated that the peptidoglycan layer of Mycobacterium spp. is largely cross-linked by 3¡3 transpeptide linkages (6-8). A significant effort was made to identify L,D-transpeptidases based on the hypothesis that they may be close sequence homologs of D,D-transpeptidases (9, 10). In E. coli, altered growth rates and susceptibility to -lactams have been reported in relation to changes in the composition of 3¡3 linkages in the peptidoglycan (4, 11). An increase in the proportion of 3¡3 transpeptide linkages reduces growth rates and subsequently decreases the susceptibility of E. coli to -lactams.Inhibition of the biosynthesis of the peptidoglycan layer has been successfully exploited, as drugs that target this layer are the most widely used antibiotics to treat bacterial infections in humans. -Lactams, a class of drugs that inhibit peptidoglycan biosynthesis, comprise more than half of all antibiotics regularly prescribed to treat bacterial infections (12). The -lactams act by inhibiting D,D-transpeptidases (also known as penicillin-binding proteins), a class of enzymes that catalyze the formation of transpeptide linkages between the fourth amino acid of one peptide stem and the third amino acid of another stem. Recently, a complementary class of enzymes, namely, L,D-transpeptidases, that transfer peptide linkage between the L and D centers of the third and the fourth amino acids of donor peptide to the third amino acid of acceptor peptide has been identified in numerous bacteria, including Enterococcus faecium, Bacillus subtilis, Mycobacterium tuberculosis, Clostridium difficile, and E. coli (6,(13)(14)(15)(16)(17)(18). Despite the significance of D,D-transpeptidases, which serve as targets to the most widely used class of antibiotics, the study of the relevance of L,D-transpeptidases to the physiology of the cell and susceptibility to drugs has only recently begun. Within 6 months following the first report describing the crystal structure and mechanism of L,Dtranspeptidation by Ldt Mt2 (19), four additional reports describing structural details of L,D-transpeptidases of M. tuberculosis were published (20-23).The M. tuberculosis genome encodes as many as five proteins with L,D-transpeptidase activity, namely, Ldt Mt1 to Ldt Mt5 (6,16,24). While biochemical properties and the contribution of Ldt Mt2 to the physiology of M. tuberculosis have been reported (16,(19)(20)(21)(22), studies of Ldt Mt1 have been limited to bioc...